New eye implant could rival standard glaucoma surgery

NCT ID NCT07496957

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a tiny drainage device called the Preserflo MicroShunt can lower eye pressure as well as the standard trabeculectomy surgery in adults with open-angle glaucoma. One hundred participants will be randomly assigned to receive one of the two procedures and will be followed for 12 months. The goal is to see if the MicroShunt is a safe and effective alternative that may be less invasive.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Preserflo MicroShunt (a tiny drainage device) and trabeculectomy (a surgical procedure)

What this could lead to

If the Preserflo MicroShunt works as well as trabeculectomy, it could offer a less invasive surgical option for controlling eye pressure in glaucoma patients.

What could go wrong

This is a relatively small, early-stage comparison study (100 participants) and the device may not prove as effective or safe as the standard surgery. Complications like scarring or infection are possible with both procedures.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NORMAL TENSION GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

exfoliation syndrome glaucoma 1, open angle, l low tension glaucoma open-angle glaucoma pigment dispersion syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Medical University of Bialystok

    RECRUITING

    Bialystok, Polska, 15-089, Poland

    Contact Phone: •••-•••-•••• Email: •••••@•••••